Pentafluranol: Difference between revisions
CSV import |
CSV import |
||
| Line 33: | Line 33: | ||
[[Category:Synthetic estrogens]] | [[Category:Synthetic estrogens]] | ||
[[Category:Stilbestrol derivatives]] | [[Category:Stilbestrol derivatives]] | ||
<gallery> | |||
File:Pentafluranol.svg|Pentafluranol | |||
</gallery> | |||
Latest revision as of 01:48, 20 February 2025
A synthetic nonsteroidal estrogen
| Pentafluranol | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Pentafluranol is a synthetic nonsteroidal estrogen that was developed for potential use in hormone replacement therapy and other estrogen-related treatments. It belongs to a class of compounds known as stilbestrol derivatives, which are characterized by their structural similarity to the natural hormone estradiol.
Chemical structure and properties[edit]
Pentafluranol is a derivative of diethylstilbestrol, a well-known synthetic estrogen. The chemical structure of pentafluranol includes multiple fluorine atoms, which are believed to influence its biological activity and pharmacokinetics. The presence of these fluorine atoms may enhance the compound's lipophilicity, potentially affecting its distribution and metabolism in the body.
Mechanism of action[edit]
As an estrogen, pentafluranol exerts its effects by binding to and activating the estrogen receptors, which are present in various tissues throughout the body. This activation leads to the modulation of gene expression and the regulation of numerous physiological processes, including the development and maintenance of female secondary sexual characteristics, regulation of the menstrual cycle, and maintenance of bone density.
Potential therapeutic uses[edit]
Pentafluranol was investigated for its potential use in hormone replacement therapy, particularly for the treatment of symptoms associated with menopause, such as hot flashes, osteoporosis, and vaginal atrophy. However, like many synthetic estrogens, its development and use have been limited due to concerns about safety and side effects.
Safety and side effects[edit]
The use of synthetic estrogens, including pentafluranol, has been associated with an increased risk of certain adverse effects, such as thromboembolism, breast cancer, and endometrial cancer. These risks have led to caution in the use of such compounds, particularly in long-term therapy.
Related compounds[edit]
Pentafluranol is related to other synthetic estrogens, such as diethylstilbestrol and hexestrol. These compounds share similar mechanisms of action but may differ in their pharmacokinetic properties and safety profiles.
Related pages[edit]
-
Pentafluranol
